639 related articles for article (PubMed ID: 30734227)
1. Systematic Review of miRNA as Biomarkers in Alzheimer's Disease.
Swarbrick S; Wragg N; Ghosh S; Stolzing A
Mol Neurobiol; 2019 Sep; 56(9):6156-6167. PubMed ID: 30734227
[TBL] [Abstract][Full Text] [Related]
2. A Systematic Review of MicroRNA Expression as Biomarker of Late-Onset Alzheimer's Disease.
Herrera-Espejo S; Santos-Zorrozua B; Álvarez-González P; Lopez-Lopez E; Garcia-Orad Á
Mol Neurobiol; 2019 Dec; 56(12):8376-8391. PubMed ID: 31240600
[TBL] [Abstract][Full Text] [Related]
3. Serum microRNA miR-501-3p as a potential biomarker related to the progression of Alzheimer's disease.
Hara N; Kikuchi M; Miyashita A; Hatsuta H; Saito Y; Kasuga K; Murayama S; Ikeuchi T; Kuwano R
Acta Neuropathol Commun; 2017 Jan; 5(1):10. PubMed ID: 28137310
[TBL] [Abstract][Full Text] [Related]
4. Can Peripheral MicroRNA Expression Data Serve as Epigenomic (Upstream) Biomarkers of Alzheimer's Disease?
Yılmaz ŞG; Erdal ME; Özge AA; Sungur MA
OMICS; 2016 Aug; 20(8):456-61. PubMed ID: 27501295
[TBL] [Abstract][Full Text] [Related]
5. Circulating miRNAs as potential biomarkers in Alzheimer's disease.
Galimberti D; Villa C; Fenoglio C; Serpente M; Ghezzi L; Cioffi SM; Arighi A; Fumagalli G; Scarpini E
J Alzheimers Dis; 2014; 42(4):1261-7. PubMed ID: 25024331
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA expression data analysis to identify key miRNAs associated with Alzheimer's disease.
Chen J; Qi Y; Liu CF; Lu JM; Shi J; Shi Y
J Gene Med; 2018 Jun; 20(6):e3014. PubMed ID: 29543360
[TBL] [Abstract][Full Text] [Related]
7. Association of Blood MicroRNA Expression and Polymorphisms with Cognitive and Biomarker Changes in Older Adults.
Sadlon A; Takousis P; Evangelou E; Prokopenko I; Alexopoulos P; Udeh-Momoh CM; Price G; Middleton L; Perneczky R
J Prev Alzheimers Dis; 2024; 11(1):230-240. PubMed ID: 38230736
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA Expression Signature in Mild Cognitive Impairment Due to Alzheimer's Disease.
De Felice B; Montanino C; Oliva M; Bonavita S; Di Onofrio V; Coppola C
Mol Neurobiol; 2020 Nov; 57(11):4408-4416. PubMed ID: 32737762
[TBL] [Abstract][Full Text] [Related]
9. microRNA diagnostic panel for Alzheimer's disease and epigenetic trade-off between neurodegeneration and cancer.
Nagaraj S; Zoltowska KM; Laskowska-Kaszub K; Wojda U
Ageing Res Rev; 2019 Jan; 49():125-143. PubMed ID: 30391753
[TBL] [Abstract][Full Text] [Related]
10. MicroRNAs in plasma and cerebrospinal fluid as potential markers for Alzheimer's disease.
Kiko T; Nakagawa K; Tsuduki T; Furukawa K; Arai H; Miyazawa T
J Alzheimers Dis; 2014; 39(2):253-9. PubMed ID: 24157723
[TBL] [Abstract][Full Text] [Related]
11. A 9-microRNA Signature in Serum Serves as a Noninvasive Biomarker in Early Diagnosis of Alzheimer's Disease.
Guo R; Fan G; Zhang J; Wu C; Du Y; Ye H; Li Z; Wang L; Zhang Z; Zhang L; Zhao Y; Lu Z
J Alzheimers Dis; 2017; 60(4):1365-1377. PubMed ID: 29036818
[TBL] [Abstract][Full Text] [Related]
12. Development of Computational Correlations among Known Drug Scaffolds and their Target-Specific Non-Coding RNA Scaffolds of Alzheimer's Disease.
Roy D; Kundu S; Mukherjee S
Curr Alzheimer Res; 2023; 20(8):539-556. PubMed ID: 37870052
[TBL] [Abstract][Full Text] [Related]
13. Profiling of Serum Exosome MiRNA Reveals the Potential of a MiRNA Panel as Diagnostic Biomarker for Alzheimer's Disease.
Dong Z; Gu H; Guo Q; Liang S; Xue J; Yao F; Liu X; Li F; Liu H; Sun L; Zhao K
Mol Neurobiol; 2021 Jul; 58(7):3084-3094. PubMed ID: 33629272
[TBL] [Abstract][Full Text] [Related]
14. Are circulating microRNAs peripheral biomarkers for Alzheimer's disease?
Kumar S; Reddy PH
Biochim Biophys Acta; 2016 Sep; 1862(9):1617-27. PubMed ID: 27264337
[TBL] [Abstract][Full Text] [Related]
15. RNA and Oxidative Stress in Alzheimer's Disease: Focus on microRNAs.
Nunomura A; Perry G
Oxid Med Cell Longev; 2020; 2020():2638130. PubMed ID: 33312335
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA Profiling of CSF Reveals Potential Biomarkers to Detect Alzheimer`s Disease.
Denk J; Boelmans K; Siegismund C; Lassner D; Arlt S; Jahn H
PLoS One; 2015; 10(5):e0126423. PubMed ID: 25992776
[TBL] [Abstract][Full Text] [Related]
17. Aberrant expression of microRNAs as biomarker for schizophrenia: from acute state to partial remission, and from peripheral blood to cortical tissue.
Lai CY; Lee SY; Scarr E; Yu YH; Lin YT; Liu CM; Hwang TJ; Hsieh MH; Liu CC; Chien YL; Udawela M; Gibbons AS; Everall IP; Hwu HG; Dean B; Chen WJ
Transl Psychiatry; 2016 Jan; 6(1):e717. PubMed ID: 26784971
[TBL] [Abstract][Full Text] [Related]
18. CSF microRNA Profiling in Alzheimer's Disease: a Screening and Validation Study.
Dangla-Valls A; Molinuevo JL; Altirriba J; Sánchez-Valle R; Alcolea D; Fortea J; Rami L; Balasa M; Muñoz-García C; Ezquerra M; Fernández-Santiago R; Lleó A; Lladó A; Antonell A
Mol Neurobiol; 2017 Nov; 54(9):6647-6654. PubMed ID: 27738874
[TBL] [Abstract][Full Text] [Related]
19. The miRNome of Alzheimer's disease: consistent downregulation of the miR-132/212 cluster.
Pichler S; Gu W; Hartl D; Gasparoni G; Leidinger P; Keller A; Meese E; Mayhaus M; Hampel H; Riemenschneider M
Neurobiol Aging; 2017 Feb; 50():167.e1-167.e10. PubMed ID: 27816213
[TBL] [Abstract][Full Text] [Related]
20. MicroRNAs in Alzheimer's disease: differential expression in hippocampus and cell-free cerebrospinal fluid.
Müller M; Kuiperij HB; Claassen JA; Küsters B; Verbeek MM
Neurobiol Aging; 2014 Jan; 35(1):152-8. PubMed ID: 23962497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
